Drug intelligence / Profile preview

qianliebeixi capsule

Development stage
Unknown
Lead developer
Conba Pharmaceutical
Administration
Oral
01

Overview

Qianliebeixi capsule is a Chinese Patent Medicine (CPM) primarily indicated for the treatment of chronic prostatitis and benign prostatic hyperplasia (BPH). It is a multi-ingredient herbal formulation composed of several traditional Chinese medicinal herbs, including *Lycopus lucidus*, *Vaccaria segetalis*, and *Astragalus membranaceus*. The drug is designed to alleviate symptoms such as pelvic pain, urinary frequency, and urgency by exerting anti-inflammatory and analgesic effects. Mechanistically, it works by improving local microcirculation in the prostate, reducing tissue edema, and modulating the levels of pro-inflammatory cytokines in the prostatic fluid. In clinical practice, it is often evaluated as a monotherapy or in combination with alpha-blockers like tamsulosin for National Institutes of Health (NIH) category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Brand names
Qianliebeixi前列倍喜
Other names
Qianlie Beixi capsule
02

Targets

IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on qianliebeixi capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qianliebeixi capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call